Skip to Content

Live Oak Health Sciences LOGSX Fund Analysis

| Quantitative rating as of | See Oak Associates Investment Hub

Morningstar’s Analysis LOGSX

Will LOGSX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.



Live Oak Health Sciences's Average Process Pillar and People Pillar ratings hold this strategy's Morningstar Quantitative Rating of Neutral. Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the second-costliest quintile among peers.

Unlock our full analysis with Morningstar Investor